Objectives: To analyse the prevalence of alpha-fodrin antibodies in patients with primary (pSS) and secondary Sjögren's syndrome (sSS) and the relation to clinical, serological and immunological features.
Methods: Serum IgA and IgG antibodies to the 120 kDa alpha-fodrin were determined by ELISA technique in 62 pSS patients and 28 sSS patients. Results were correlated with clinical symptoms and laboratory findings as well as with the HLA-DR genotype. Additionally, antibody concentrations were correlated with the numbers of peripheral blood mononuclear cells (PBMCs) secreting interleukin (IL)-6, IL-10, interferon-gamma (INF)-gamma, and tumour necrosis factor-alpha determined by ELISPOT analysis. Lymphocytes and monocytes were examined flow-cytometrically for the expression of activation markers. Healthy age- and sex-matched volunteers served as controls.
Results: The sensitivity of IgA and IgG alpha-fodrin antibodies was 35 and 31%, respectively, in pSS patients. In sSS patients, the sensitivity was 29 and 21%, respectively. In pSS patients with IgG antibodies, recurrent parotid swelling was significantly more prevalent. Also the number of INF-gamma secreting PBMCs and the percentage of CD4/CD71+ lymphocytes as well as CD14/HLA-DR+ monocytes were significantly increased in this group compared with alpha-fodrin-negative patients or with controls. Interestingly, these patients also had a shorter disease duration. No association of alpha-fodrin antibodies with the HLA-DR genotype was found.
Conclusion: Due to the low prevalence, serum antibodies to alpha-fodrin turned out to be of limited diagnostic value in our study. However, our data suggest that IgG antibodies to alpha-fodrin are indicative of clinical and immunological activity in pSS especially in patients with shorter disease duration and may thus serve as a marker of disease activity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/rheumatology/kel270 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Humoral Immunity Abnormalities in Advanced Maternal-Age Women With Recurrent Spontaneous Abortion: A Single Center Study].
Sichuan Da Xue Xue Bao Yi Xue Ban
May 2024
（ 200092） Department of Reproductive Immunity of Shanghai First Maternity and Infant Hospital, Shanghai 200092, China.
Objective: To determine the humoral immunity in advanced maternal-age women with recurrent spontaneous abortion (RSA).
Methods: A retrospective study was performed between January 2022 and October 2023 in the Department of Reproductive Immunity of Shanghai First Maternity and Infant Hospital. Women with RSA were recruited and multiple autoantibodies were tested.
Human umbilical cord mesenchymal stem cells improve disease characterization of Sjogren's syndrome in NOD mice through regulation of gut microbiota and Treg/Th17 cellular immunity.
Immun Inflamm Dis
January 2024
Department of Rheumatology and Immunology, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, Hunan, China.
Article Synopsis
- The study investigates the potential of human umbilical cord mesenchymal stem cells (UC-MSCs) and their derived exosomes (UC-MSCs-exo) in treating Sjogren's syndrome (SS) by focusing on their effects on T cells from Nonobese Diabetic (NOD) mice.
- Results showed that co-culturing T cells with UC-MSCs and UC-MSCs-exo led to a reduction in inflammatory cytokines, an increase in anti-inflammatory markers, and improved function in salivary secretion.
- Additionally, the treatment influenced Treg/Th17 cell balance, decreased inflammatory cell infiltration in key areas, and positively impacted intestinal health, suggesting a promising therapeutic approach for
Characteristics of primary Sjögren's syndrome-associated peripheral nervous system lesions.
J Neurol
November 2023
Department of Neurology, Nanfang Hospital, Southern Medical University, 1838# North Guangzhou Avenue, Guangzhou, 510515, China.
Objective: The aim of this study is to investigate potential risk factors associated with peripheral nervous system lesions in primary Sjögren's syndrome (pSS) through a retrospective analysis of clinical manifestations, examination characteristics, and clinical electrophysiological features.
Materials And Methods: A retrospective case-control study was conducted at Nanfang Hospital, including 108 patients diagnosed with pSS following the criteria revised by the American College of Rheumatology in 2016. The study spanned from January 2015 to October 2020.
[Practicable diagnostics of Sjögren's syndrome in interstitial lung disease-A discussion article].
Z Rheumatol
May 2023
Klinik für Rheumatologie und Immunologie, Medizinische Hochschule Hannover, Hannover, Deutschland.
Sjögren's syndrome (SjS) is a possible autoimmune cause of interstitial lung disease. The diagnostic pathway for SjS, however, is largely undefined in comparison to other systemic autoimmune diseases. Subjective sicca symptoms, anti-SS-A/Ro antibodies and even ANA as screening tests all have relevant limitations in sensitivity and/or specificity.
View Article and Find Full Text PDFEvaluation of Diagnostic Accuracy of Alpha-Fodrin Antibody in Iranian Patients with Sjogren's Disease.
Adv Biomed Res
July 2022
Department of Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Background: Sjogren's syndrome, as a chronic autoimmune disease, involves in lymphocytic infiltration in the exocrine glands. As the result of exocrine glands disruption, the clinical hallmark of this disease including dryness of mouth and eyes along with fatigue and joint pain occur. However, heterogeneity of clinical presentations among newly diagnosed adult patients with Sjogren's syndrome leads to difficulty in its diagnosis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!